. .
Clinical Stem 2
A patient with pulmonary nodules one year after curative intent resection of primary lung adenocarcinoma
Learning Outcome


At the conclusion of the 2nd Clinical Stem webcast, viewers will be able to:
  1. Describe patient management strategies to assure adequate material is obtained from small samples for lung cancer diagnosis and molecular analysis.
  2. Describe rationales for molecular testing for diagnosis or in case of rebiopsy.
  3. Describe optimization strategies for acquisition and handling of small cytology and histology samples.
  4. Describe laboratory processing requirements of small cytology and histology samples to ensure that sufficient material is available for molecular analysis.
Narrative Companion to Clinical Stem 2
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology